Cargando…
Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids
One major challenge associated with lung cancer organoids (LCOs) is their predominant derivation from surgical specimens of patients with early-stage lung cancer. However, patients with advanced lung cancer, who are in need of chemotherapy, often cannot undergo surgery. Therefore, there is an urgent...
Autores principales: | Park, Dongil, Lee, Dahye, Kim, Yoonjoo, Park, Yeonhee, Lee, Yeon-Jae, Lee, Jeong Eun, Yeo, Min-Kyung, Kang, Min-Woong, Chong, Yooyoung, Han, Sung Joon, Choi, Jinwook, Park, Jong-Eun, Koh, Yongjun, Lee, Jaehyeok, Park, YongKeun, Kim, Ryul, Lee, Jeong Seok, Choi, Jimin, Lee, Sang-Hyun, Ku, Bosung, Kang, Da Hyun, Chung, Chaeuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377875/ https://www.ncbi.nlm.nih.gov/pubmed/37508518 http://dx.doi.org/10.3390/cells12141854 |
Ejemplares similares
-
The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer
por: Kang, Da Hyun, et al.
Publicado: (2022) -
The Tri-iodothyronine (T3) Level Is a Prognostic Factor for Patients With Advanced NSCLC: Receiving Immune Checkpoint Inhibitors and Is Associated With Liver Metastasis
por: Kim, Yoonjoo, et al.
Publicado: (2022) -
Early detection of delayed pneumothorax using lung ultrasound after transthoracic needle lung biopsy: A prospective pilot study
por: Koh, Jeong Suk, et al.
Publicado: (2022) -
Changes in Oxygenation and Serological Markers in Acute Exacerbation of Interstitial Lung Disease Treated with Polymyxin B Hemoperfusion
por: Lee, Song-I, et al.
Publicado: (2022) -
Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2021)